Cargando…

Assessing and testing anomaly detection for finding prostate cancer in spatially registered multi-parametric MRI

BACKGROUND: Evaluating and displaying prostate cancer through non-invasive imagery such as Multi-Parametric MRI (MP-MRI) bolsters management of patients. Recent research quantitatively applied supervised target algorithms using vectoral tumor signatures to spatially registered T1, T2, Diffusion, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayer, Rulon, Turkbey, Baris, Choyke, Peter, Simone, Charles B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869917/
https://www.ncbi.nlm.nih.gov/pubmed/36698418
http://dx.doi.org/10.3389/fonc.2022.1033323
_version_ 1784876868093083648
author Mayer, Rulon
Turkbey, Baris
Choyke, Peter
Simone, Charles B.
author_facet Mayer, Rulon
Turkbey, Baris
Choyke, Peter
Simone, Charles B.
author_sort Mayer, Rulon
collection PubMed
description BACKGROUND: Evaluating and displaying prostate cancer through non-invasive imagery such as Multi-Parametric MRI (MP-MRI) bolsters management of patients. Recent research quantitatively applied supervised target algorithms using vectoral tumor signatures to spatially registered T1, T2, Diffusion, and Dynamic Contrast Enhancement images. This is the first study to apply the Reed-Xiaoli (RX) multi-spectral anomaly detector (unsupervised target detector) to prostate cancer, which searches for voxels that depart from the background normal tissue, and detects aberrant voxels, presumably tumors. METHODS: MP-MRI (T1, T2, diffusion, dynamic contrast-enhanced images, or seven components) were prospectively collected from 26 patients and then resized, translated, and stitched to form spatially registered multi-parametric cubes. The covariance matrix (CM) and mean μ were computed from background normal tissue. For RX, noise was reduced for the CM by filtering out principal components (PC), regularization, and elliptical envelope minimization. The RX images were compared to images derived from the threshold Adaptive Cosine Estimator (ACE) and quantitative color analysis. Receiver Operator Characteristic (ROC) curves were used for RX and reference images. To quantitatively assess algorithm performance, the Area Under the Curve (AUC) and the Youden Index (YI) points for the ROC curves were computed. RESULTS: The patient average for the AUC and [YI] from ROC curves for RX from filtering 3 and 4 PC was 0.734[0.706] and 0.727[0.703], respectively, relative to the ACE images. The AUC[YI] for RX from modified Regularization was 0.638[0.639], Regularization 0.716[0.690], elliptical envelope minimization 0.544[0.597], and unprocessed CM 0.581[0.608] using the ACE images as Reference Image. The AUC[YI] for RX from filtering 3 and 4 PC was 0.742[0.711] and 0.740[0.708], respectively, relative to the quantitative color images. The AUC[YI] for RX from modified Regularization was 0.643[0.648], Regularization 0.722[0.695], elliptical envelope minimization 0.508[0.605], and unprocessed CM 0.569[0.615] using the color images as Reference Image. All standard errors were less than 0.020. CONCLUSIONS: This first study of spatially registered MP-MRI applied anomaly detection using RX, an unsupervised target detection algorithm for prostate cancer. For RX, filtering out PC and applying Regularization achieved higher AUC and YI using ACE and color images as references than unprocessed CM, modified Regularization, and elliptical envelope minimization.
format Online
Article
Text
id pubmed-9869917
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98699172023-01-24 Assessing and testing anomaly detection for finding prostate cancer in spatially registered multi-parametric MRI Mayer, Rulon Turkbey, Baris Choyke, Peter Simone, Charles B. Front Oncol Oncology BACKGROUND: Evaluating and displaying prostate cancer through non-invasive imagery such as Multi-Parametric MRI (MP-MRI) bolsters management of patients. Recent research quantitatively applied supervised target algorithms using vectoral tumor signatures to spatially registered T1, T2, Diffusion, and Dynamic Contrast Enhancement images. This is the first study to apply the Reed-Xiaoli (RX) multi-spectral anomaly detector (unsupervised target detector) to prostate cancer, which searches for voxels that depart from the background normal tissue, and detects aberrant voxels, presumably tumors. METHODS: MP-MRI (T1, T2, diffusion, dynamic contrast-enhanced images, or seven components) were prospectively collected from 26 patients and then resized, translated, and stitched to form spatially registered multi-parametric cubes. The covariance matrix (CM) and mean μ were computed from background normal tissue. For RX, noise was reduced for the CM by filtering out principal components (PC), regularization, and elliptical envelope minimization. The RX images were compared to images derived from the threshold Adaptive Cosine Estimator (ACE) and quantitative color analysis. Receiver Operator Characteristic (ROC) curves were used for RX and reference images. To quantitatively assess algorithm performance, the Area Under the Curve (AUC) and the Youden Index (YI) points for the ROC curves were computed. RESULTS: The patient average for the AUC and [YI] from ROC curves for RX from filtering 3 and 4 PC was 0.734[0.706] and 0.727[0.703], respectively, relative to the ACE images. The AUC[YI] for RX from modified Regularization was 0.638[0.639], Regularization 0.716[0.690], elliptical envelope minimization 0.544[0.597], and unprocessed CM 0.581[0.608] using the ACE images as Reference Image. The AUC[YI] for RX from filtering 3 and 4 PC was 0.742[0.711] and 0.740[0.708], respectively, relative to the quantitative color images. The AUC[YI] for RX from modified Regularization was 0.643[0.648], Regularization 0.722[0.695], elliptical envelope minimization 0.508[0.605], and unprocessed CM 0.569[0.615] using the color images as Reference Image. All standard errors were less than 0.020. CONCLUSIONS: This first study of spatially registered MP-MRI applied anomaly detection using RX, an unsupervised target detection algorithm for prostate cancer. For RX, filtering out PC and applying Regularization achieved higher AUC and YI using ACE and color images as references than unprocessed CM, modified Regularization, and elliptical envelope minimization. Frontiers Media S.A. 2023-01-05 /pmc/articles/PMC9869917/ /pubmed/36698418 http://dx.doi.org/10.3389/fonc.2022.1033323 Text en Copyright © 2023 Mayer, Turkbey, Choyke and Simone https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Mayer, Rulon
Turkbey, Baris
Choyke, Peter
Simone, Charles B.
Assessing and testing anomaly detection for finding prostate cancer in spatially registered multi-parametric MRI
title Assessing and testing anomaly detection for finding prostate cancer in spatially registered multi-parametric MRI
title_full Assessing and testing anomaly detection for finding prostate cancer in spatially registered multi-parametric MRI
title_fullStr Assessing and testing anomaly detection for finding prostate cancer in spatially registered multi-parametric MRI
title_full_unstemmed Assessing and testing anomaly detection for finding prostate cancer in spatially registered multi-parametric MRI
title_short Assessing and testing anomaly detection for finding prostate cancer in spatially registered multi-parametric MRI
title_sort assessing and testing anomaly detection for finding prostate cancer in spatially registered multi-parametric mri
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869917/
https://www.ncbi.nlm.nih.gov/pubmed/36698418
http://dx.doi.org/10.3389/fonc.2022.1033323
work_keys_str_mv AT mayerrulon assessingandtestinganomalydetectionforfindingprostatecancerinspatiallyregisteredmultiparametricmri
AT turkbeybaris assessingandtestinganomalydetectionforfindingprostatecancerinspatiallyregisteredmultiparametricmri
AT choykepeter assessingandtestinganomalydetectionforfindingprostatecancerinspatiallyregisteredmultiparametricmri
AT simonecharlesb assessingandtestinganomalydetectionforfindingprostatecancerinspatiallyregisteredmultiparametricmri